Modifying factors of the HFE hemochromatosis phenotype

References

• Finch C. Iron metabolism in hemochromatosis. J. Clin. Invest.28, 780 (1949).
   Google Scholar
• Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N. Engl. J. Med.313(20), 1256–1262 (1985).
   PubMed Web of Science ®Google Scholar
• Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut17(5), 332–334 (1976).
   PubMed Web of Science ®Google Scholar
• Simon M, Bourel M, Genetet B, Fauchet R. Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing. N. Engl. J. Med.297(19), 1017–1021 (1977).
   PubMed Web of Science ®Google Scholar
• Feder JN, Gnirke A, Thomas W et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet.13(4), 399–408 (1996).
   PubMed Web of Science ®Google Scholar
• Pietrangelo A. Non-HFE hemochromatosis. Hepatology39(1), 21–29 (2004).
   PubMed Web of Science ®Google Scholar
• Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet. Test.4(2), 183–198 (2000).
   PubMedGoogle Scholar
• Brissot P, Moirand R, Jouanolle AM et al. A genotypic study of 217 unrelated probands diagnosed as “genetic hemochromatosis” on “classical” phenotypic criteria. J. Hepatol.30(4), 588–593 (1999).
   PubMedGoogle Scholar
• Anderson GJ, Darshan D, Wilkins SJ, Frazer DM. Regulation of systemic iron homeostasis: how the body responds to changes in iron demand. Biometals20(3–4), 665–674 (2007).
   PubMed Web of Science ®Google Scholar
• Ganz T. Molecular control of iron transport. J. Am. Soc. Nephrol.18(2), 394–400 (2007).
   PubMed Web of Science ®Google Scholar
• Ganz T. Iron homeostasis: fitting the puzzle pieces together. Cell Metab.7(4), 288–290 (2008).
   PubMed Web of Science ®Google Scholar
• Pigeon C, Ilyin G, Courselaud B et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem.276(11), 7811–7819 (2001).
   PubMed Web of Science ®Google Scholar
• Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood101(7), 2461–2463 (2003).
   PubMed Web of Science ®Google Scholar
• Nicolas G, Bennoun M, Devaux I et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl Acad. Sci. USA98(15), 8780–8785 (2001).
   PubMed Web of Science ®Google Scholar
• De Domenico I, Ward DM, Langelier C et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol. Biol. Cell18(7), 2569–2578 (2007).
   PubMed Web of Science ®Google Scholar
• Nemeth E, Tuttle MS, Powelson J et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science306(5704), 2090–2093 (2004).
   PubMed Web of Science ®Google Scholar
• Bekri S, Gual P, Anty R et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology131(3), 788–796 (2006).
   PubMed Web of Science ®Google Scholar
• Peyssonnaux C, Zinkernagel AS, Datta V, Lauth X, Johnson RS, Nizet V. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood107(9), 3727–3732 (2006).
   PubMed Web of Science ®Google Scholar
• Nicolas G, Chauvet C, Viatte L et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest.110(7), 1037–1044 (2002).
   PubMed Web of Science ®Google Scholar
• Babitt JL, Huang FW, Wrighting DM et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet.38(5), 531–539 (2006).
   PubMed Web of Science ®Google Scholar
• Truksa J, Peng H, Lee P, Beutler E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc. Natl Acad. Sci. USA103(27), 10289–10293 (2006).
   PubMed Web of Science ®Google Scholar
• Wang RH, Li C, Xu X et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab.2(6), 399–409 (2005).
   PubMed Web of Science ®Google Scholar
• Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J. Clin. Invest.117(7), 1933–1939 (2007).
   PubMed Web of Science ®Google Scholar
• Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, Ganz T. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood110(6), 2182–2189 (2007).
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ, Andrews NC. The transferrin receptor modulates HFE-dependent regulation of hepcidin expression. Cell Metab.7(3), 205–214 (2008).
   PubMed Web of Science ®Google Scholar
• Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J.374(Pt 1), 1–20 (2003).
   PubMed Web of Science ®Google Scholar
• Pietrangelo A, Dierssen U, Valli L et al. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology132(1), 294–300 (2007).
   PubMed Web of Science ®Google Scholar
• Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood109(1), 353–358 (2007).
   PubMed Web of Science ®Google Scholar
• Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood108(9), 3204–3209 (2006).
   PubMed Web of Science ®Google Scholar
• Fukuda S, Abematsu M, Mori H et al. Potentiation of astrogliogenesis by STAT3-mediated activation of bone morphogenetic protein–SMAD signaling in neural stem cells. Mol. Cell. Biol.27(13), 4931–4937 (2007).
   PubMed Web of Science ®Google Scholar
• Tanno T, Bhanu NV, Oneal PA et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat. Med.13(9), 1096–1101 (2007).
   PubMed Web of Science ®Google Scholar
• Courselaud B, Pigeon C, Inoue Y et al. C/EBPα regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J. Biol. Chem.277(43), 41163–41170 (2002).
   PubMed Web of Science ®Google Scholar
• Pinto JP, Ribeiro S, Pontes H et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signalling and regulation of C/EBPα. Blood (2008) (In press).
   Google Scholar
• Harrison-Findik DD. Role of alcohol in the regulation of iron metabolism. World J. Gastroenterol.13(37), 4925–4930 (2007).
   PubMedGoogle Scholar
• Brissot P, de Bels F. Current approaches to the management of hemochromatosis. Hematology36–41 (2006).
   PubMedGoogle Scholar
• Deugnier Y, Turlin B, le Quilleuc D et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am. J. Surg. Pathol.21(6), 669–675 (1997).
   PubMed Web of Science ®Google Scholar
• Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology112(3), 882–888 (1997).
   PubMed Web of Science ®Google Scholar
• Asberg A, Hveem K, Thorstensen K et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand. J. Gastroenterol.36(10), 1108–1115 (2001).
   PubMed Web of Science ®Google Scholar
• Adams PC, Reboussin DM, Barton JC et al. Hemochromatosis and iron-overload screening in a racially diverse population. N. Engl. J. Med.352(17), 1769–1778 (2005).
   PubMed Web of Science ®Google Scholar
• Allen KJ, Gurrin LC, Constantine CC et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N. Engl. J. Med.358(3), 221–230 (2008).
   PubMed Web of Science ®Google Scholar
• Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Hemochromatosis mutations in the general population: iron overload progression rate. Blood103(8), 2914–2919 (2004).
   PubMed Web of Science ®Google Scholar
• Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G⊠A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet359(9302), 211–218 (2002).
   PubMed Web of Science ®Google Scholar
• Deugnier Y, Mosser J. The genotype–phenotype interaction in HFE hemochromatosis. Expert Rev. Gastroenterol. Hepatol. (2008) (In Press).
   Google Scholar
• Jackson HA, Carter K, Darke C et al. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br. J. Haematol.114(2), 474–484 (2001).
   PubMed Web of Science ®Google Scholar
• Deugnier Y, Jouanolle AM, Chaperon J et al. Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people. Br. J. Haematol.118(4), 1170–1178 (2002).
   PubMedGoogle Scholar
• Guyader D, Jacquelinet C, Moirand R et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology115(4), 929–936 (1998).
   PubMed Web of Science ®Google Scholar
• Piippo K, Louhija J, Tilvis R, Kontula K. You may live to the age of more than 100 years even if you are homozygous for a haemochromatosis gene mutation. Eur. J. Clin. Invest.33(9), 830–831 (2003).
   PubMedGoogle Scholar
• Coppin H, Bensaid M, Fruchon S, Borot N, Blanche H, Roth MP. Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenarians. Br. Med. J.327(7407), 132–133 (2003).
   PubMedGoogle Scholar
• Van Aken MO, De Craen AJ, Gussekloo J et al. No increase in mortality and morbidity among carriers of the C282Y mutation of the hereditary haemochromatosis gene in the oldest old: the Leiden 85-plus study. Eur. J. Clin. Invest.32(10), 750–754 (2002).
   PubMedGoogle Scholar
• Waalen J, Nordestgaard BG, Beutler E. The penetrance of hereditary hemochromatosis. Best Pract. Res. Clin. Haematol.18(2), 203–220 (2005).
   PubMedGoogle Scholar
• Burt MJ, George PM, Upton JD et al. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut43(6), 830–836 (1998).
   PubMedGoogle Scholar
• Merryweather-Clarke AT, Worwood M, Parkinson L et al. The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population. Br. J. Haematol.101(2), 369–373 (1998).
   PubMedGoogle Scholar
• Njajou OT, Houwing-Duistermaat JJ, Osborne RH et al. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism. Eur. J. Hum. Genet.11(3), 225–231 (2003).
   PubMed Web of Science ®Google Scholar
• Crawford DH, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology114(5), 1003–1008 (1998).
   PubMed Web of Science ®Google Scholar
• Walsh A, Dixon JL, Ramm GA et al. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Clin. Gastroenterol. Hepatol.4(11), 1403–1410 (2006).
   PubMed Web of Science ®Google Scholar
• Moirand R, Jouanolle AM, Brissot P, Le Gall JY, David V, Deugnier Y. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. Gastroenterology116(2), 372–377 (1999).
   PubMedGoogle Scholar
• Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann. Intern. Med.133(5), 329–337 (2000).
   PubMed Web of Science ®Google Scholar
• Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood93(8), 2502–2505 (1999).
   PubMed Web of Science ®Google Scholar
• Piperno A, Arosio C, Fossati L et al. Two novel nonsense mutations of HFE gene in five unrelated italian patients with hemochromatosis. Gastroenterology119(2), 441–445 (2000).
   PubMedGoogle Scholar
• Wallace DF, Dooley JS, Walker AP. A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote. Gastroenterology116(6), 1409–1412 (1999).
   PubMed Web of Science ®Google Scholar
• Steiner M, Ocran K, Genschel J et al. A homozygous HFE gene splice site mutation (IVS5+1 G/A) in a hereditary hemochromatosis patient of Vietnamese origin. Gastroenterology122(3), 789–795 (2002).
   PubMedGoogle Scholar
• van der AD, Peeters PH, Grobbee DE, Roest M, Voorbij HA, van der Schouw YT. HFE genotypes and dietary heme iron: no evidence of strong gene-nutrient interaction on serum ferritin concentrations in middle-aged women. Nutr. Metab. Cardiovasc. Dis.16(1), 60–68 (2006).
   PubMedGoogle Scholar
• Cade JE, Moreton JA, O’Hara B et al. Diet and genetic factors associated with iron status in middle-aged women. Am. J. Clin. Nutr.82(4), 813–820 (2005).
   PubMed Web of Science ®Google Scholar
• Kaltwasser JP, Werner E, Schalk K, Hansen C, Gottschalk R, Seidl C. Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut43(5), 699–704 (1998).
   PubMed Web of Science ®Google Scholar
• Bridle K, Cheung TK, Murphy T et al. Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin. Exp. Res.30(1), 106–112 (2006).
   PubMed Web of Science ®Google Scholar
• Detivaud L, Nemeth E, Boudjema K et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood106(2), 746–748 (2005).
   PubMed Web of Science ®Google Scholar
• Barton JC, Preston BL, McDonnell SM, Rothenberg BE. Severity of iron overload in hemochromatosis: effect of volunteer blood donation before diagnosis. Transfusion41(1), 123–129 (2001).
   PubMedGoogle Scholar
• Laine F, Jouannolle AM, Morcet J et al. Phenotypic expression in detected C282Y homozygous women depends on body mass index. J. Hepatol.43(6), 1055–1059 (2005).
   PubMed Web of Science ®Google Scholar
• Laine F, Deugnier Y. Increased expression of hepcidin in obese patients: impact on phenotypic expression of hemochromatosis and pathophysiology of dysmetabolic iron overload syndrome. Gastroenterology131(6), 2028 (2006).
   PubMedGoogle Scholar
• Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med.341(10), 718–724 (1999).
   PubMed Web of Science ®Google Scholar
• Distante S, Berg JP, Lande K, Haug E, Bell H. HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut47(4), 575–579 (2000).
   PubMed Web of Science ®Google Scholar
• Beutler E, Waalen J, Gelbart T. Chronic inflammation does not appear to modify the homozygous hereditary hemochromatosis phenotype. Blood Cells Mol. Dis.35(3), 326–327 (2005).
   PubMedGoogle Scholar
• Hutchinson C, Geissler CA, Powell JJ, Bomford A. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut56(9), 1291–1295 (2007).
   PubMed Web of Science ®Google Scholar
• Ludwiczek S, Theurl I, Muckenthaler MU et al. Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. Nat. Med.13(4), 448–454 (2007).
   PubMed Web of Science ®Google Scholar
• Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann. Intern. Med.127(2), 105–110 (1997).
   PubMed Web of Science ®Google Scholar
• Bulaj ZJ, Ajioka RS, Phillips JD et al. Disease-related conditions in relatives of patients with hemochromatosis. N. Engl. J. Med.343(21), 1529–1535 (2000).
   PubMed Web of Science ®Google Scholar
• Whiting PW, Fletcher LM, Dixon JK, Gochee P, Powell LW, Crawford DH. Concordance of iron indices in homozygote and heterozygote sibling pairs in hemochromatosis families: implications for family screening. J. Hepatol.37(3), 309–314 (2002).
   PubMedGoogle Scholar
• Whitfield JB, Cullen LM, Jazwinska EC et al. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am. J. Hum. Genet.66(4), 1246–1258 (2000).
   PubMed Web of Science ®Google Scholar
• Bensaid M, Fruchon S, Mazeres C, Bahram S, Roth MP, Coppin H. Multigenic control of hepatic iron loading in a murine model of hemochromatosis. Gastroenterology126(5), 1400–1408 (2004).
   PubMedGoogle Scholar
• Jacolot S, Le Gac G, Scotet V, Quere I, Mura C, Ferec C. HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. Blood103(7), 2835–2840 (2004).
   PubMed Web of Science ®Google Scholar
• Merryweather-Clarke AT, Cadet E, Bomford A et al. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum. Mol. Genet.12(17), 2241–2247 (2003).
   PubMed Web of Science ®Google Scholar
• Le Gac G, Scotet V, Ka C et al. The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum. Mol. Genet.13(17), 1913–1918 (2004).
   PubMed Web of Science ®Google Scholar
• Milet J, Dehais V, Bourgain C et al. Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate hfe hemochromatosis penetrance. Am. J. Hum. Genet.81(4), 799–807 (2007).
   PubMed Web of Science ®Google Scholar
• Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology122(2), 281–289 (2002).
   PubMed Web of Science ®Google Scholar
• Loreal O, Deugnier Y, Moirand R et al. Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients. J. Hepatol.16(1–2), 122–127 (1992).
   PubMed Web of Science ®Google Scholar
• Powell EE, Ali A, Clouston AD et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology129(6), 1937–1943 (2005).
   PubMed Web of Science ®Google Scholar
• Livesey KJ, Wimhurst VL, Carter K et al. The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading. J. Med. Genet.41(1), 6–10 (2004).
   PubMed Web of Science ®Google Scholar
• Beutler E, Beutler L, Lee PL, Barton JC. The mitochondrial nt 16189 polymorphism and hereditary hemochromatosis. Blood Cells Mol. Dis.33(3), 344–345 (2004).
   PubMedGoogle Scholar
• Osterreicher CH, Datz C, Stickel F et al. TGF-β1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis. Cytokine31(2), 142–148 (2005).
   PubMed Web of Science ®Google Scholar
• Valenti L, Conte D, Piperno A et al. The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis. J. Med. Genet.41(12), 946–950 (2004).
   PubMed Web of Science ®Google Scholar